肝炎病人 的英文怎麼說

中文拼音 [gānyánbìngrén]
肝炎病人 英文
a patient with hepatitis
  • 肝 : 名詞（人和高等動物的消化器官之一） liver
  • 炎 : Ⅰ形容詞（極熱） scorching; burning hot Ⅱ名詞（炎癥） imflammation
  • 病 : Ⅰ名詞1 （疾病; 失去健康的狀態） illness; sickness; disease; malum; nosema; malady; morbus; vitium...
  • 肝炎 : hepatitis （pl. hepatitides）肝炎病毒 [病毒] hepatitis virus
  • 病人 : patient; invalid
  1. Glaxosmithkline does market 3tc in china - but only combined with another drug, azt, as a dual therapy fdc tablet, or in a dosage which is suitable for treating hepatitis b but not recommended for hiv aids. the lack of access to a generic triple fdc forces msf and others to pay five times more for first - line arv treatment in china than in cambodia

    葛蘭素在中國銷售拉米夫定，但只與另一種成分多夫定製成的二合一固定劑量組合，而非較理想的三合一固定劑量組合，亦沒有適合治療愛滋病的劑量，只有醫治乙型肝炎病人的劑量。
  2. Before hepatitis patient is choosing qigong treatment, the pathology of main basis liver, bravery, lienal, stomach will generalize measure of baconian diagnosis and treatment, when choosing qigong method yi yinggen occupies a men and women old young physiology is different, the constitution loses by force each different and individual qigong accomplishment and main symptom will choose more the result method of suit, but a little collective also principle

    肝炎病人在選擇氣功療法前，主要根據肝、膽、脾、胃的病理來概括歸納診療措施，在選擇氣功方法時亦應根據男女老幼生理不同，體質強弱各異以及個體的氣功素養和主要癥狀來選擇更加切合的功法，但也有些共同原則。
  3. According to coming from spanish report, the person that medicaments of the abuse inside hemophiliac, vein becomes addiction and blood are dialytic patient, rate of positive of antibody of third hepatitis virus is respectively 64 %, 70 % reach 20 %, more average crowd is apparently tall

    據來自西班牙的報告，血友病患者、靜脈內濫用藥物成癮者及血液透析患者，丙型肝炎病毒抗體陽性率分別為64 % 、 70 %及20 % ，較一般人群明顯為高。
  4. Hepatitis patient often has the enteron symptom of different level, if be disgusted with is fat, meal hind is abdominal distension, do not think of food to wait, the different breath method in tone breath can be used when qigong takes exercise, and knead an abdomen, massage wait for auxiliary result to adjust gastric bowel peristalsis and abdomen are pressed, eliminate clinical symptom

    肝炎病人常有不同程度的消化道癥狀，如厭油膩，飯后腹脹，不思飲食等，在氣功鍛煉時可借用調息中的不同呼吸法，以及揉腹、按摩等輔助功調節胃腸蠕動和腹壓，消除臨床癥狀。
  5. Nucleoside and nucleotide analogues are usually long - term therapy, potentially life - long, for people with chronic hepatitis b

    核甘類似物和核甘酸類似物用作治療慢性乙型肝炎，病人一般需要長期甚至終生接受治療。
  6. For example : liver advocate anger, hepatitis patient often is behaved move restlessly restlessly, easily for the mood, irritable, love gets angry, or be agitated falls asleep hard, because this acrobatics wants special attention too quiet this closes, the attention moves the argument of meaning in result method, wu begs song jing, with benefit diseases with such symptoms as coastal pain tone is amounted to

    例如：肝主怒，肝炎病人經常表現為情緒不寧、易躁動、易怒、愛發脾氣，或煩躁難以入睡，因此練功要非凡注重過安靜這一關，注重功法中調意的要旨，務求松靜，以利肝氣調達。
  7. But there also is what do not suit qigong cure in hepatitis patient, weigh disease hepatitis for example, illness development is rapid, often be after the foreboding symptom such as calorific, disgusting, vomiting, icteric be deepened very quickly and appear haemorrhage, ascites, spirit is unusual, develop even for hepatic coma, the patient ' s condition is unusual in a extremely dangerous state

    但肝炎病人中也有不適合氣功治療的，例如重癥肝炎，病情發展迅速，常在發熱、惡心、嘔吐等先兆癥狀后，黃疸很快加深並出現出血、腹水、精神異常，甚至發展為肝昏迷，病情異常兇險。
  8. The food of hepatitis patient and nutrition are another in cure important segment

    肝炎病人的飲食與營養是治療中的又一個重要環節。
  9. Short - term effect of lamivudine with gan bi tuo treatment in patients with hepatits b

    拉米夫定聯合苷必妥治療慢性乙型肝炎病人的近期療效
  10. Clinical observation of lamivudine therapy in 50 patients with chronic hepatitis b infection

    拉米夫定治療中國慢性乙型肝炎病人2年的臨床研究
  11. In saudi arabia, according to recent statistics, there are 500, 000 people with hepatitis c, representing 2. 7 percent of world ' s hepatitis patients

    根據最近的統計在沙烏地阿拉伯有50萬人感染了丙肝，佔世界上肝炎病人的2 . 7 。
  12. Will tell commonly, patient of armour hepatitis or the fifth of the ten heavenly stem hepatitis, the person that cure above of half an year can enter acuteness activity

    一般來講，甲型肝炎或戊型肝炎病人，治愈半年以上者可以參加劇烈活動。
  13. Conclusion the primary measure to reduce the mortality of fulminant hepatitis is to take precautionary measures to reduce the secondary infections in hepatitis b patients

    結論降低重型肝炎的病死率首先做好預防，減少乙型肝炎病人的繼發感染。
  14. Therefore, how to enhance awareness of the disease, intensify prevention and raise individual health care ability in hepatitis patients has become problems of great concern

    因此，如何提高肝癌的防病意識和手段，提高肝炎病人自我保健能力，是我們值得關心的課題。
  15. The shorter duration of treatment for genotype 1 hcv and good safety profile is likely to contribute to good treatment compliance and therefore offers the opportunity of a good treatment response

    此聯合治療可為基因一型的丙型肝炎病人提供較短的療程及更佳的依從性，從而提升治療效果。
  16. 257 asian chronic hepatitis c patients with active disease were recruited and randomly assigned in 1 : 1 ratio to receive interferon beta - 1a or placebo treatment for 12 weeks in a double - blinded manner

    研究招募了二百五十七名亞裔慢性丙型肝炎病人，以一比一的比例隨機分為兩組，分別注射干擾素beta - 1a或安慰劑，進行十二周的雙盲研究。
  17. And hepatitis b patient, although self - conscious symptom disappears, liver meritorious service is regular, but cannot think already heal, must want to make antigen of second liver surface turns after shade, just be to be cured completely

    而乙型肝炎病人，雖自覺癥狀消失，肝功正常，但不能認為已經痊癒，必須要使乙肝表面抗原轉陰后，才是完全治愈。
  18. New study demonstrates telbivudine s superiority to adefovir in hepatitis b treatment both newly diagnosed hepatitis b patients and those who have previously taken adefovir, a widely prescribed treatment for the disease, will see improved viral suppression with telbivudine, according to a new study presented at the asian pacific association for the study of liver apasl meeting in kyoto, japan

    亞太肝臟學會（ apasl ）在日本京都發表最新研究報告指出，無論是乙型肝炎新癥以及一些正在服用傳統藥物阿德?偉（ adefovir ）的乙型肝炎病人，在服用新一代的口服乙肝藥制劑替比夫定（ telbivudine ）后，可更有效抑制病毒復制，為乙型肝炎患者的新選擇。
  19. Elisa system for the detection of anti - e2 antibodies in patients " sera was established using aa 385 - 730 fragment, which detected anti - e2 in 56 % of hepatitis c patients and demonstrated a correlation between anti - e2 and hcv viraemia

    利用aa385 - 730片段，建立了病人血清中抗e2抗體的elisa檢測體系，該體系在56 %的丙型肝炎病人血清內檢出了抗e2抗體，並且發現抗e2抗體的存在與hcv病毒血癥存在正相關。
  20. In immuno - blotting, these fragments reacted specifically with hepatitis c patients " sera, suggesting that e. coli - derived e2 proteins carried hcv e2 - specific, glycosylation - and - conformation - independent epitopes

    在免疫印跡檢測中，上述片段與丙型肝炎病人血清有特異性反應，表明大腸桿菌系統表達的e2蛋白攜帶有hcve2特異的、不依賴于糖化和立體構象的抗原決定簇。
分享友人
分享到 Line

分享到臉書